Shengrong Lin

Shengrong Lin possesses extensive experience in research and development within the biotechnology sector. Currently serving as Associate VP of R&D at Agilent Technologies, Shengrong Lin previously co-founded and held the position of CEO at Avida Biomed and AccuraGen, where also served as President and CTO. Earlier roles include working as a scientist at Illumina and conducting postdoctoral research at Stanford University. Shengrong Lin earned a Ph.D. in Molecular Pathology from UC San Diego and an M.D. in Clinical Medicine from Fudan University.